Abstract
Cancer is a common and diverse disease that has been studied for decades. Some tumors have rapid growth while some tumors progress slowly. Researchers have identified different types of anticancer drugs that control cell division and multiplication. But there is an urge to identify new anticancer agents, as tumor cells somehow, succeed in developing resistance. Some anticancer drugs target uncontrolled dividing cells and cause cell cycle arrest while some drugs are used as targeted agents that earmark the mutated receptors and block tumor formation. This chapter describes the primary targets of anticancer drugs, including enzymes involved in cellular replication and particular mutations in receptors leading to tumor development. Targeted drug therapy works more efficiently and produces remission. All anticancer drugs possess teratogenic effects.
| Original language | English |
|---|---|
| Title of host publication | Cancer Targeting Therapies |
| Subtitle of host publication | Conventional and Advanced Perspectives |
| Publisher | CRC Press |
| Pages | 97-114 |
| Number of pages | 18 |
| ISBN (Electronic) | 9781000982930 |
| ISBN (Print) | 9781032426259 |
| DOIs | |
| State | Published - 1 Jan 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2024 selection and editorial matter, Muhammad Yasir Ali, Shazia Anwer Bukhari; individual chapters, the contributors.
ASJC Scopus subject areas
- General Medicine
- General Pharmacology, Toxicology and Pharmaceutics